137 related articles for article (PubMed ID: 349258)
21. Comparative study on the responses of plasma GH to synthetic GH-releasing factor and other stimulatory and inhibitory agents in patients with acromegaly.
Hanew K; Sato S; Sasaki A; Shimizu Y; Murakami O; Yoshinaga K
Tohoku J Exp Med; 1985 Feb; 145(2):161-6. PubMed ID: 2859672
[TBL] [Abstract][Full Text] [Related]
22. Plasma growth hormone responses to sulpiride in patients with acromegaly.
Hanew K; Sato S; Sasaki A; Kasai M; Shimizu Y; Murakami O; Yoshinaga K
Tohoku J Exp Med; 1984 Apr; 142(4):445-52. PubMed ID: 6429896
[TBL] [Abstract][Full Text] [Related]
23. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
[TBL] [Abstract][Full Text] [Related]
24. Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly.
Arosio M; Giovanelli MA; Riva E; Nava C; Ambrosi B; Faglia G
J Neurosurg; 1983 Sep; 59(3):402-8. PubMed ID: 6411870
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the results of trans-sphenoidal surgery in acromegaly by assessment of the growth hormone response to thyrotrophin-releasing hormone.
Faglia G; Paracchi A; Ferrari C; Beck-Peccoz P
Clin Endocrinol (Oxf); 1978 May; 8(5):373-80. PubMed ID: 417883
[TBL] [Abstract][Full Text] [Related]
26. Luteinizing hormone-releasing hormone and serum growth hormone in insulin-dependent diabetes.
Joffe BI; Distiller LA; Sagel J; Lawson M; Morley JE; Seftel HC
S Afr Med J; 1977 Jun; 51(26):979-80. PubMed ID: 329438
[TBL] [Abstract][Full Text] [Related]
27. Discordant effects of insulin-hypoglycemia on growth hormone (GH)-releasing hormone-stimulated GH and thyrotropin (TSH)-releasing hormone-stimulated TSH secretion.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1988 Apr; 66(4):872-5. PubMed ID: 3126217
[TBL] [Abstract][Full Text] [Related]
28. [Growth hormone secretion in acromegaly after isolated and combined use of the insulin hypoglycemia, LH-RH and TRH test].
Schneider KR; Wiegelmann W; Solbach HG; Krüskemper HL
Verh Dtsch Ges Inn Med; 1978; (84):1438-41. PubMed ID: 105492
[No Abstract] [Full Text] [Related]
29. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
Hoyte KM; Martin JB
J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
[TBL] [Abstract][Full Text] [Related]
30. [Stimulation of growth hormone and prolactin secretion with TRH in acromegaly (author's transl)].
von Werder K; Fahlbusch R; Gay R; Pickhardt CR; Schultz B
Klin Wochenschr; 1976 Apr; 54(7):335-8. PubMed ID: 177804
[TBL] [Abstract][Full Text] [Related]
31. Enhanced GH responses to combined administration of GHRP and GHRH in patients with acromegaly.
Hanew K; Utsumi A; Sugawara A; Shimizu Y; Abe K
J Clin Endocrinol Metab; 1994 Mar; 78(3):509-12. PubMed ID: 8126120
[TBL] [Abstract][Full Text] [Related]
32. Differences in autonomity of growth hormone secretion in patients with acromegaly.
Hanew K; Aida M; Tano T; Ojima M; Nishizato K
Tohoku J Exp Med; 1976 Oct; 120(2):159-67. PubMed ID: 824758
[TBL] [Abstract][Full Text] [Related]
33. Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment.
Boizel R; Halimi S; Labat F; Cohen R; Bachelot I
J Clin Endocrinol Metab; 1987 Feb; 64(2):304-8. PubMed ID: 3098773
[TBL] [Abstract][Full Text] [Related]
34. Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion.
Arosio M; Ambrosi B; Guglielmino L; Faglia G
J Endocrinol Invest; 1985 Oct; 8(5):449-53. PubMed ID: 2867112
[TBL] [Abstract][Full Text] [Related]
35. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
[TBL] [Abstract][Full Text] [Related]
36. Paradoxical response of growth hormone to peptide histidine methionine in acromegaly: comparison with the effects of thyrotropin-releasing hormone and vasoactive intestinal peptide.
Watanobe H; Sasaki S; Sone K; Takebe K
J Clin Endocrinol Metab; 1991 May; 72(5):982-5. PubMed ID: 1902488
[TBL] [Abstract][Full Text] [Related]
37. Assessment of GH releasing hormone activity in sephadex-separated fractions of porcine hypothalamic extracts by hypophyseal portal vessel infusion in the rat.
Takahara J; Arimura A; Schally AV
Acta Endocrinol (Copenh); 1975 Mar; 78(3):428-34. PubMed ID: 235186
[TBL] [Abstract][Full Text] [Related]
38. [Growth hormone, gonadotropins and cortisol in the plasma of males under combined application of the insulin-hypoglycaemia-LH-RH test (author's transl)].
Wiegelmann W; Kley HK; Solbach HG; Krüskemper HL
Klin Wochenschr; 1974 Feb; 52(4):194-6. PubMed ID: 4600183
[No Abstract] [Full Text] [Related]
39. Do "so-called" normal growth hormone concentrations (2-5 micrograms/l) indicate cure in acromegaly?
Levitt NS; Ratanjee BD; Abrahamson MJ
Horm Metab Res; 1995 Apr; 27(4):185-8. PubMed ID: 7750902
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of growth hormone by vasoactive intestinal polypeptide in acromegaly.
Chihara K; Kaji H; Minamitani N; Kodama H; Kita T; Goto B; Chiba T; Coy DH; Fujita T
J Clin Endocrinol Metab; 1984 Jan; 58(1):81-6. PubMed ID: 6417157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
